Drug class
Reversible inhibitor of monoamine oxidase A (RIMA); antidepressant
Mechanism of action
Reversibly and selectively inhibits monoamine oxidase type A, reducing metabolism of noradrenaline, serotonin and dopamine and increasing their extracellular availability in the central nervous system.
General use cases
- Treatment of depressive episodes in adults under the applicable product information; local authorisation and precautions for use with serotonergic medicines must be checked
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
